Abstract:BACKGROUND:It has been reported that osteopontin has an important role in cardiac fibrosis and remodeling. However, its direct mechanisms remain unclear. The purpose of this study was to investigate the role of angiotensin and aldosterone blockades in cardiac osteopontin expression associated with cardiac remodeling in myocardial infarcted (MI) rats.METHODS:Fifty SD rats that survived 24 hours after ligating left anterior descending coronary artery were randomly divided into three groups: MI-saline group (n = 15, 5 ml/d), MI-perindopril group (n = 18, perindopril 2 mgxkg(-1)d(-1)) and MI-spironolacton (n = 17, spironolacton 20 mgxkg(-1)xd(-1)). A sham operation group (n = 15) was selected as non-infarcted control. At 6 weeks after treatment, hemodynamic pararmeters and left ventricular function were measured with catheterization, interstitial fibrosis infiltration and cardiomyocyte diameters were evaluated histologically. Myocardium osteopontin protein expression level in the non-infarcted myocardium was detected by Western blotting.RESULTS:No osteopontin protein was detected in the myocardium of sham-operation rats. High levels of osteopontin protein expression were detected in the MI-saline rats, but the levels were suppressed in the MI-perindopril and MI-spironolacton rats at 6 weeks following MI (P < 0.01, respectively). Compared with the sham operation group, all rats in the MI group showed marked interstitial fibrosis infiltration in the non-infarction area, higher ventricular weight/body weight ratio, significantly increased cardiomyocyte diameter (P < 0.01, respectively), and developed significant systolic and diastolic dysfunction as indicated by decreased left ventricular systolic pressure (LVSP) and +/-dp/dt, as well as increased left ventricular end-diastolic pressure (LVEDP) (P < 0.01, respectively). Angiotensin and aldosterone blockades partly prevented cardiac fibrosis and systolic and diastolic dysfunction (P < 0.01, respectively).CONCLUSION:Treatment with angiotensin and aldosterone blockades inhibits expression of osteopontin in the non-infarcted myocardium and prevents cardiac remodeling following MI.

Expression And Function Of Osteopontin In Vascular Adventitial Fibroblasts And Pathological Vascular Remodeling

Osteopontin is required for vascular endothelial growth factor receptor-1-mediated vascular inflammation in vascular adventitia

Osteopontin in Bone Metabolism and Bone Diseases

Vascular Endothelial Growth Factor–Induced Osteopontin Expression Mediates Vascular Inflammation and Neointima Formation Via Flt-1 in Adventitial Fibroblasts

Expression of Osteopontin in Adventitia and Its Influence on Adventitial Fibroblast Migration

[Osteopontin Enhances Migratory Ability of Cultured Aortic Adventitial Fibroblasts from Spontaneously Hypertensive Rats].

Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin Ii - Induced Cardiac Hypertrophy

Role of Osteopontin in Angiotensin Ii-Induced Cardiac Fibrosis and Remodeling

The Effect of Osteopontin on Microglia

Pathophysiological Role of Osteopontin and Angiotensin II in Atherosclerosis.

Osteopontin is involved in urotensin II-induced migration of rat aortic adventitial fibroblasts

Osteopontin is a key regulator of vascular smooth muscle cell proliferation in the outflow vein of arteriovenous fistulas

Osteopontin induces vascular endothelial growth factor expression in articular cartilage through PI3K/AKT and ERK1/2 signaling

Pathophysiological role of osteopontin and angiotensin II in atherosclerosis

Blockades of Angiotensin and Aldosterone Reduce Osteopontin Expression and Interstitial Fibrosis Infiltration in Rats with Myocardial Infarction.

Osteopontin Induces Atrial Fibrosis by Activating Akt/GSK-3β/β-catenin Pathway and Suppressing Autophagy.

Osteopontin Promotes Angiogenesis in the Spinal Cord and Exerts a Protective Role Against Motor Function Impairment and Neuropathic Pain after Spinal Cord Injury

Osteopontin Acts As a Negative Regulator of Autophagy Accelerating Lipid Accumulation During the Development of Nonalcoholic Fatty Liver Disease

Expression, roles, receptors, and regulation of osteopontin in the kidney

The Critical Role of Osteopontin (OPN) in Fibrotic Diseases

Osteopontin Regulates Macrophage Activation and Osteoclast Formation in Hypertensive Patients with Vascular Calcification